search
Back to results

NEXUS - Next Generation Health Through 2D & 3D Fetal UltraSound; Building Connections to Support Maternal-fetal Health (NEXUS)

Primary Purpose

Pregnancy Related, Substance Use, Mental Health Issue

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
NEXUS intervention
Standardized Non-Medical fetal ultrasound
Sponsored by
Virginia Commonwealth University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Pregnancy Related

Eligibility Criteria

18 Years - 45 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Pregnant persons, Aged 18 through 45, between 22-32 weeks gestation at study entry Provision of signed and dated informed consent form Not incarcerated Able to read and understand English For infants after delivery, parental informed consent to participate in the study Stated willingness to comply with all study procedures Meets Diagnostic and Statistical Manual 5 criteria for Substance Abuse or substance use disorder in the last 12 months or is in active treatment for substance use disorder (including Nicotine/Tobacco, alcohol, marijuana, illicit and licit substances, and opioids) or actively using substances during pregnancy. Willingness to participate in the NEXUS regimen Exclusion Criteria: Presenting with cognitive impairment psychiatric instability (active psychosis or acute mania) language or legal barriers that would limit the patient's ability to provide informed consent and complete research assessments. Known fetal anomalies Medical conditions requiring frequent ultrasound monitoring outside the study (e.g. Gestational Diabetes)

Sites / Locations

  • Virginia Commonwealth UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Comparator

NEXUS Intervention

Arm Description

Standardized non-diagnostic fetal ultrasound protocol without interactive intervention to control for time and attention.

Standardized non-diagnostic fetal ultrasound with motivational interviewing techniques, focused on maternal and fetal strengths.

Outcomes

Primary Outcome Measures

Study Retention
Percentage of each group returning for a second study visit
Parent Subjective Connection to Fetus/Infant
Participants reported scores of maternal-fetal attachment at the Baseline visit and at last postpartum session; Maternal-fetal attachment scale; Parent-Infant Attachment Questionnaire at 12 weeks post-delivery; (0-5 score, higher is better)
Prenatal care utilization
The number of prenatal care visits per week of gestation at delivery.
Substance use treatment utilization
The number of substance use/mental health treatment visits per week of gestation at delivery.

Secondary Outcome Measures

Access to Care
PRAMS access to care survey
Perceived Stress
Perceived Stress Scale
Substance use in pregnancy
Participants' reported substance use at weekly check-ins during and after pregnancy: total number of days using substances in pregnancy (tobacco, alcohol, illicit drugs, marijuana).
Obstetric complications
The total number of Obstetrics Complications identified by participant reports and medical record occurring from pregnancy through 12 weeks postpartum.

Full Information

First Posted
March 3, 2023
Last Updated
June 12, 2023
Sponsor
Virginia Commonwealth University
search

1. Study Identification

Unique Protocol Identification Number
NCT05814575
Brief Title
NEXUS - Next Generation Health Through 2D & 3D Fetal UltraSound; Building Connections to Support Maternal-fetal Health
Acronym
NEXUS
Official Title
Community-based Fetal Ultrasound and Care Navigation: An Approach to Engaging Pregnant Women With Substance Use Disorder in Prenatal Care and Substance Use Treatment
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 8, 2023 (Actual)
Primary Completion Date
September 2024 (Anticipated)
Study Completion Date
October 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Virginia Commonwealth University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This exploratory study brings together an interprofessional team, novel tools, and innovative, community-driven care delivery approaches to improve health equity among mother-infant dyads impacted by substance use disorder and high risk for poor health outcomes. This study will test a community-informed and community-based intervention using a fetal ultrasound protocol, motivational interviewing techniques, strength-based education, and healthcare coordination strategies to reduce health disparities faced by women and their children.
Detailed Description
Engaging women earlier in pregnancy through innovative, yet sustainable methods, will improve consistency in prenatal care and substance use treatment which will translate into substantially improved maternal and infant outcomes. The overarching premise is that successful engagement of women in accessible care during pregnancy will lead to earlier and more sustained prenatal care and treatment and lower risk for poor outcomes. This study is a multi-pronged approach to offer: (1) community-informed and community-located protocols to engage individuals into prenatal care as early as possible; (2) a novel fetal ultrasound protocol to enhance maternal-fetal connection and stimulate motivation for self-management and prenatal care; and, (3) navigation and care coordination, to connect individuals to personalized services and treatment. The NEXUS intervention is based on the idea that visualizing the fetus and seeing behavioral patterns in-utero will increase a person's sense of attachment to the fetus and in turn increase motivation for self-care and avoidance of risky behaviors. The NEXUS protocol includes a standardized fetal neurobehavioral assessment, measures of fetal growth, and, importantly, a component of 'attachment promotion' as it is a natural extension to share with the pregnant person the behavioral and social strengths of their unborn child. As the woman observes the fetus on the monitor (a second external monitor is set up for easy viewing by the mother), she may also feel fetal movement simultaneously in the womb (after 23 weeks gestation), creating a visual and sensory link between the mother and fetus. A trained nurse or ultrasonographer shares observations of fetal behavior with the mother and others if present. The family is given pictures and videos of the infant to take home with them. The NEXUS protocol will be repeated approximately 4 weeks after the first session, with educational content focused on the development of the fetus, changes in physical function, behaviors, and growth. This is a small community-based randomized control trial in which 60 pregnant women with substance use disorder (or treatment for substance use disorder) will be offered two prenatal study visits, between the 2nd and 3rd trimesters, with two follow-up visits in the first 4 months after infant delivery. Participants will be recruited from communities with high health disparities and randomly assigned to either: (1) the Comparator Group which receives a standard non-diagnostic ultrasound with minimal interaction and no accompanying education or, (2) NEXUS Intervention Group which receives the NEXUS fetal ultrasound protocol that includes motivational interviewing and content specific to emotional and cognitive connection with the fetus. The prenatal ultrasound visits and the follow-up visits will be offered within the community in which the participant lives. All participants will receive standardized education, care coordination, and weekly contact with care navigators.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pregnancy Related, Substance Use, Mental Health Issue

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Comparator
Arm Type
Active Comparator
Arm Description
Standardized non-diagnostic fetal ultrasound protocol without interactive intervention to control for time and attention.
Arm Title
NEXUS Intervention
Arm Type
Experimental
Arm Description
Standardized non-diagnostic fetal ultrasound with motivational interviewing techniques, focused on maternal and fetal strengths.
Intervention Type
Behavioral
Intervention Name(s)
NEXUS intervention
Intervention Description
During the fetal ultrasound protocol, the NEXUS intervention is added for the component of 'attachment promotion' as it is a natural extension to share with the pregnant person the behavioral and social strengths of their unborn child. As the participant observes the fetus on the monitor (a second external monitor is set up for easy viewing by the mother), she may also feel fetal movement simultaneously in the womb (after 23 weeks gestation), creating a visual and sensory link between the mother and fetus. A trained nurse or ultrasonographer shares observations of fetal behavior with the mother and others if present. The nurse is also trained in motivational interviewing techniques to use the strengths of the mother and those attributed to her fetus to explore readiness to change and other motivational factors that may be barriers to health promotion.
Intervention Type
Behavioral
Intervention Name(s)
Standardized Non-Medical fetal ultrasound
Intervention Description
A standardized protocol using non-diagnostic fetal ultrasound that includes basic maternal-fetal health assessment by a trained nurse, fetal neurobehavioral assessment, measures of fetal growth, and pictures & videos given to parents.
Primary Outcome Measure Information:
Title
Study Retention
Description
Percentage of each group returning for a second study visit
Time Frame
10-26 weeks
Title
Parent Subjective Connection to Fetus/Infant
Description
Participants reported scores of maternal-fetal attachment at the Baseline visit and at last postpartum session; Maternal-fetal attachment scale; Parent-Infant Attachment Questionnaire at 12 weeks post-delivery; (0-5 score, higher is better)
Time Frame
Baseline through 12 Weeks post-delivery
Title
Prenatal care utilization
Description
The number of prenatal care visits per week of gestation at delivery.
Time Frame
Immediately following infant birth
Title
Substance use treatment utilization
Description
The number of substance use/mental health treatment visits per week of gestation at delivery.
Time Frame
Immediately following infant birth
Secondary Outcome Measure Information:
Title
Access to Care
Description
PRAMS access to care survey
Time Frame
26 weeks
Title
Perceived Stress
Description
Perceived Stress Scale
Time Frame
26 weeks
Title
Substance use in pregnancy
Description
Participants' reported substance use at weekly check-ins during and after pregnancy: total number of days using substances in pregnancy (tobacco, alcohol, illicit drugs, marijuana).
Time Frame
Immediately following infant birth
Title
Obstetric complications
Description
The total number of Obstetrics Complications identified by participant reports and medical record occurring from pregnancy through 12 weeks postpartum.
Time Frame
12 weeks postpartum

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Pregnant persons, Aged 18 through 45, between 22-32 weeks gestation at study entry Provision of signed and dated informed consent form Not incarcerated Able to read and understand English For infants after delivery, parental informed consent to participate in the study Stated willingness to comply with all study procedures Meets Diagnostic and Statistical Manual 5 criteria for Substance Abuse or substance use disorder in the last 12 months or is in active treatment for substance use disorder (including Nicotine/Tobacco, alcohol, marijuana, illicit and licit substances, and opioids) or actively using substances during pregnancy. Willingness to participate in the NEXUS regimen Exclusion Criteria: Presenting with cognitive impairment psychiatric instability (active psychosis or acute mania) language or legal barriers that would limit the patient's ability to provide informed consent and complete research assessments. Known fetal anomalies Medical conditions requiring frequent ultrasound monitoring outside the study (e.g. Gestational Diabetes)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Andrea Publow
Phone
804-828-6772
Email
dirospa@vcu.edu
Facility Information:
Facility Name
Virginia Commonwealth University
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23298
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amy L Salisbury, PhD
Phone
804-828-2095
Email
salisburya@vcu.edu
First Name & Middle Initial & Last Name & Degree
Ariel Hill-Thomas
Email
hillthomasa@vcu.edu
First Name & Middle Initial & Last Name & Degree
Amy Salisbury, PhD
First Name & Middle Initial & Last Name & Degree
Patricia Kinser, PhD
First Name & Middle Initial & Last Name & Degree
Dace Svikis, PhD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Anonymized participant data will be shared in a standard data repository.
IPD Sharing Time Frame
To be determined
IPD Sharing Access Criteria
To be determined

Learn more about this trial

NEXUS - Next Generation Health Through 2D & 3D Fetal UltraSound; Building Connections to Support Maternal-fetal Health

We'll reach out to this number within 24 hrs